Konstanze Hurth
Inventor
Stats
- 24 US patents issued
- 44 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 24 US Patents Issued
- 44 US Applications Filed
- 197 Total Citation Count
- Jan 20, 2023 Most Recent Filing
- Sep 3, 2003 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| NOVARTIS AG | 2
2 6 2 4 2 8 3 11 5 9 4 2 | 2003
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2017 |
| GENTSCH, CONRAD | 1
| 2005
|
| NOVARTIS PHARMA GMBH | 4
| 2006
|
| VASSOUT, ANNICK | 1
| 2005
|
| FEUERBACH, DOMINIK | 1
| 2005
|
| BILBE, GRAEME | 1
| 2005
|
| HURTH, KONSTANZE | 1
| 2005
|
| KALKMAN, HANS O. | 1
| 2005
|
| ROY, BERNARD LUCIEN | 1
| 2005
|
| NOZULAK, JOACHIM | 1
| 2005
|
Inventor Addresses
| Address | Duration |
|---|---|
| Basel, CH | Nov 29, 12 - Jan 15, 15 |
| Lörrach, DE | Apr 10, 25 - Apr 10, 25 |
| Loerrach, DE | Jul 19, 12 - Jan 28, 14 |
| Lorrach, DE | Jan 27, 11 - Jun 16, 20 |
| Saint Louis, DE | Feb 26, 09 - Feb 26, 09 |
| Saint Louis, FR | Jul 08, 04 - Mar 21, 19 |
| Sant Louis, FR | Jan 26, 12 - Jan 26, 12 |
| St. Genis Pouilly, FR | Aug 11, 11 - Dec 01, 11 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 42 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 20 |
| C07B: | GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0115,572 | 2025 | SPIROCYCLIC PIPERIDINYL DERIVATIVES AS COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF | 0 |
| 10683287 | 2020 | Heterocyclic derivatives and their use in the treatment of neurological disorders | 0 |
| 2020/0048,236 | 2020 | Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders | 0 |
| 10301296 | 2019 | Heterocyclic derivatives and their use in the treatment of neurological disorders | 1 |
| 2019/0083,474 | 2019 | AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.